8-K: Estée Lauder Reports FY25 Loss, Eyes FY26 Growth

Sentiment:

Annual Results


Estée Lauder Companies reported a significant net loss for fiscal year 2025, driven by sales declines and impairment charges, but forecasts a return to organic sales growth and improved profitability in fiscal 2026.

Worse than expectedFiscal year 2025 net sales decreased 8%, while organic net sales also decreased 8%.The company reported a net loss of $(1.133) billion for fiscal 2025, a significant deterioration from net earnings of $409 million in the prior year.Diluted net loss per common share was $(3.15), compared to net earnings of $1.08 in the prior year.Operating income shifted to a loss of $(785) million from a profit of $970 million in fiscal 2024.Adjusted operating income decreased 28% and adjusted operating margin contracted 220 basis points.Net cash flows provided by operating activities decreased by over $1 billion.The company incurred substantial goodwill and other intangible asset impairment charges totaling $1.286 billion.A U.S. deferred tax asset valuation allowance adjustment of $172 million was established, reflecting uncertainty about the realizability of deferred tax assets.

Summary

  • Net sales for fiscal year 2025 decreased 8% to $14.326 billion, with organic net sales also down 8%.
  • The company reported a net loss of $(1.133) billion, or $(3.15) per diluted share, for fiscal 2025, compared to net earnings of $409 million, or $1.08 per diluted share, in the prior year.
  • Adjusted diluted net earnings per common share decreased 42% to $1.51 in fiscal 2025.
  • Operating loss was $(785) million, compared to operating income of $970 million in fiscal 2024, primarily due to $815 million in goodwill and other intangible asset impairment charges, $362 million in restructuring charges, and $159 million for talcum litigation settlements.
  • Adjusted operating margin contracted 220 basis points to 8.0%.
  • Gross margin expanded 230 basis points to 74.0%, driven by the Profit Recovery and Growth Plan (PRGP), operational efficiencies, and strategic pricing.
  • Net cash flows from operating activities decreased to $1.27 billion from $2.36 billion in the prior year.
  • The company paid $618 million in dividends, a reduction from $947 million in the prior year, reflecting a decision to reduce its dividend payout ratio.
  • The PRGP, expanded in February 2025, is expected to incur $1.2 billion to $1.6 billion in restructuring charges and yield annual gross benefits of $0.8 billion to $1.0 billion, with a net reduction of 5,800 to 7,000 positions.
  • As of August 13, 2025, $747 million in charges and over 3,200 net position reductions have been approved under the PRGP.
  • For fiscal 2026, the company forecasts organic net sales growth of 0% to 3% and adjusted diluted net earnings per common share between $1.90 and $2.10.
  • Fiscal 2026 adjusted operating margin is projected to be 9.4% to 9.9%, with benefits from the PRGP building sequentially.
  • The company expects tariff-related headwinds to impact fiscal 2026 profitability by approximately $100 million.

Sentiment

Score: 4

Explanation: The fiscal 2025 results are very poor, marked by significant losses, sales declines, and large impairment charges. While the company outlines a clear recovery plan (PRGP) and forecasts a return to growth and improved profitability in fiscal 2026, the current performance is deeply negative. The dividend reduction and ongoing geopolitical/economic risks add to the cautious sentiment. The score reflects the severity of the past year's performance, partially offset by a credible, albeit challenging, path to recovery.

Positives

  • Gross margin expanded 230 basis points to 74.0% in fiscal 2025, primarily due to the Profit Recovery and Growth Plan (PRGP), operational efficiencies, lower excess and obsolescence, and strategic pricing actions.
  • Achieved prestige beauty share gains in key markets, including mainland China (driven by La Mer and TOM FORD) and Japan (strengthening #1 rank in Fragrance).
  • Made significant improvement in U.S. share trends in the second half of fiscal 2025, led by The Ordinary, Clinique, and Estée Lauder.
  • Ranked highly during fiscal 2025 key shopping moments in mainland China (11.11 Global Shopping Festival, 618 Shopping Festival) with brands like Estée Lauder, La Mer, Jo Malone London, and MAC ranking highly.
  • Launched breakthrough, on-trend, and commercial innovations, extending halos of beloved franchises and capturing new trends.
  • Expanded consumer coverage through launches on Amazon's U.S. and Canada Premium Beauty stores, Shopee, and TikTok Shop.
  • Scaled distribution of The Ordinary globally, including new geographic expansions.
  • Broadened Fragrance distribution with approximately 40 net new freestanding stores globally, led by Jo Malone London and Le Labo.
  • Increased consumer-facing investments by approximately 400 basis points as a percentage of sales, funded by PRGP initiatives that reduced non-consumer-facing costs by 6%.
  • Opened a new BioTech Hub in Belgium and established a collaboration with the Massachusetts Institute of Technology (MIT) to accelerate biotechnology innovations.
  • Recognized for investments and expanded strategic AI partnerships with Microsoft and Adobe to drive operational efficiencies and empower creative teams.
  • Enhanced supply chain processes to improve manufacturing efficiencies, speed-to-market, and quality.
  • Recognized by CDP for environmental impact, achieving an A for Climate, Afor Water, and B for Forests.
  • Forecasts a return to organic sales growth (0% to 3%) in fiscal 2026 after three years of declines, and a return to solid double-digit adjusted operating margin over the next few years.
  • Anticipates mid-single-digit growth in mainland China and modest growth in global travel retail for fiscal 2026.

Negatives

  • Net sales decreased 8% in fiscal 2025 to $14.326 billion, with organic net sales also down 8%.
  • Reported a net loss of $(1.133) billion for fiscal 2025, a significant decline from net earnings of $409 million in the prior year.
  • Diluted net loss per common share was $(3.15) in fiscal 2025, compared to net earnings of $1.08 in the prior year.
  • Operating income declined to a loss of $(785) million from a profit of $970 million in the prior year.
  • Adjusted operating income decreased 28% to $1.146 billion, and adjusted operating margin contracted 220 basis points to 8.0%.
  • Net cash flows provided by operating activities decreased significantly to $1.27 billion from $2.36 billion in the prior year.
  • The company reduced its quarterly dividend to $.35 per share in fiscal 2025 Q2, resulting in lower total dividends paid ($618 million vs. $947 million).
  • Skin Care net sales decreased 12%, primarily due to declines from Estée Lauder and La Mer, reflecting ongoing subdued sentiment and lower conversion from Chinese consumers, difficult comparisons to prior year, and retailer shifts in strategies in Asia travel retail.
  • Makeup net sales decreased 5%, primarily driven by declines from MAC, Estée Lauder (due to Asia travel retail challenges), Too Faced, and Bobbi Brown.
  • Hair Care net sales decreased 10%, primarily due to declines from Aveda and The Ordinary, reflecting softness in brick-and-mortar channels.
  • Operating results decreased across all geographic regions, primarily due to lower net sales and significant impairment charges.
  • Recorded $1.286 billion in goodwill and other intangible asset impairment charges in fiscal 2025, including $773 million for TOM FORD, $88 million for Too Faced, and $375 million for Dr.Jart+.
  • Incurred $159 million in aggregate charges associated with talcum litigation settlement agreements in fiscal 2025.
  • Established a U.S. deferred tax asset valuation allowance of $172 million against general foreign tax credit and research and development tax credit carryforwards, reflecting uncertainty about their realizability.
  • Fiscal 2026 outlook includes approximately $100 million in tariff-related headwinds on profitability.

Risks

  • Increased competitive activity from companies in the skin care, makeup, fragrance, and hair care businesses.
  • Ability to develop, produce, and market new products and successfully address business challenges.
  • Consolidations, restructurings, bankruptcies, and reorganizations in the retail industry, potentially decreasing store count, increasing ownership concentration, or leading to competitor/customer ownership of retailers.
  • Destocking and tighter working capital management by retailers.
  • Success, timing, or scope of new product launches and advertising/merchandising programs.
  • Shifts in consumer preferences regarding value perception and shopping habits.
  • Social, political, and economic risks to foreign or domestic operations, including changes in foreign investment, trade policies, and regulations.
  • Changes in laws, regulations, and policies (including interpretations and enforcement) affecting the business, products, distribution networks, accounting standards, tax laws, environmental/climate change laws, trade rules, customs regulations, and legal/regulatory proceedings.
  • Foreign currency fluctuations affecting results of operations, asset values, relative prices, and operating/manufacturing costs.
  • Changes in global or local conditions (e.g., credit/equity market volatility, government economic policies, disasters, epidemics, supply chain challenges, inflation, energy costs) affecting consumer purchasing, travel, financial strength of customers/suppliers, operations, capital cost/availability, pension asset returns, and raw material costs.
  • Shipment delays, commodity pricing, inventory depletion, and increased production costs from operational disruptions (e.g., IT initiatives, restructurings).
  • Real estate rates and availability affecting ability to increase/maintain retail locations and facility costs.
  • Changes in product mix to less profitable products.
  • Ability to acquire, develop, or implement new information technology (including operational technology and websites) on time and within cost estimates, maintain continuous operations, and secure data.
  • Ability to capitalize on efficiency opportunities (e.g., PRGP) and integrate acquired businesses.
  • Consequences attributable to local or international conflicts, terrorist actions, retaliation, and threats.
  • Timing and impact of acquisitions, investments, and divestitures.
  • Ongoing volatility in Asia travel retail, including weak conversion rates.
  • Subdued consumer sentiment and tighter inventory management by some retailers in mainland China.
  • Potential expiration of certain provisions in global tax regulations during fiscal 2026, which could increase the effective tax rate if not extended.
  • Higher restructuring payments expected to peak in fiscal 2026, impacting net cash flows from operating activities.
  • Impact of changes being made in the organization, including those related to Beauty Reimagined and the PRGP, as well as the potential impact of changes expected to be made as part of the PRGP on suppliers, retailers, and others.
  • Challenges relating to successfully outsourcing select services.

Future Outlook

The company anticipates a return to organic net sales growth of 0% to 3% in fiscal 2026, following three years of declines, and expects adjusted diluted net earnings per common share to be between $1.90 and $2.10. Adjusted operating margin is projected to expand to 9.4% to 9.9%, with benefits from the Profit Recovery and Growth Plan (PRGP) building sequentially throughout the year. The outlook assumes mid-single-digit growth in mainland China and modest growth in global travel retail, alongside low-single-digit growth in other markets. The company will focus on optimizing investments, prioritizing consumer-facing initiatives, and managing working capital, while monitoring geopolitical landscape, currency volatility, inflationary pressures, and supply chain challenges. Restructuring payments are expected to peak in fiscal 2026, impacting cash flow, and tariff-related headwinds are anticipated to be approximately $100 million.

Management Comments

  • Stéphane de La Faverie, President and CEO, stated: 'Having closed fiscal 2025 as expected, we remain wholly focused on continuing to execute our strategic vision of Beauty Reimagined with excellence.'
  • Stéphane de La Faverie also commented: 'Despite continued volatility in the external environment, we embarked on fiscal 2026 with signs of momentum and confidence in our outlook to deliver organic sales growth this year after three years of declines and to begin rebuilding operating profitability in pursuit of a solid double-digit adjusted operating margin over the next few years.'

Industry Context

The company's performance reflects broader challenges in the prestige beauty sector, particularly in Asia travel retail and mainland China, where subdued consumer sentiment and strategic shifts by retailers have impacted sales. Despite these headwinds, the company's ability to gain market share in key regions like mainland China, Japan, and the U.S. (in the second half of FY25) suggests resilience and effective brand management within a competitive landscape. The focus on expanding online distribution channels (Amazon, Shopee, TikTok Shop) aligns with the industry's ongoing shift towards e-commerce and direct-to-consumer models. The significant restructuring efforts and focus on operational efficiencies through the PRGP are indicative of a mature industry player adapting to evolving market dynamics and cost pressures, aiming to restore profitability and sustainable growth amidst global economic uncertainties and geopolitical tensions.

Comparison to Industry Standards

  • The company's reported 8% decline in net sales for fiscal 2025 contrasts with the forecasted global prestige beauty growth of 2% to 3% for fiscal 2026, indicating a period of underperformance relative to the broader market's expected trajectory.
  • The significant operating loss and diluted net loss per common share in fiscal 2025, largely due to substantial impairment charges ($1.286 billion) on brands like TOM FORD, Too Faced, and Dr.Jart+, suggest that certain acquisitions or brand strategies have not met internal expectations, a challenge not uncommon in the highly acquisitive beauty industry where brand integration and sustained growth can be difficult.
  • The expansion of gross margin by 230 basis points to 74.0% through operational efficiencies and strategic pricing, despite sales declines, demonstrates effective cost management and pricing power, which is a positive indicator compared to competitors who might struggle to maintain margins amidst volume pressures.
  • The company's strategic expansion into Amazon's Premium Beauty stores and other e-commerce platforms like Shopee and TikTok Shop aligns with industry leaders like L'Oréal and Coty, who are also heavily investing in digital channels to capture evolving consumer shopping behaviors.
  • The commitment to a significant restructuring program (PRGP) with expected annual gross benefits of $0.8 billion to $1.0 billion and a reduction of 5,800 to 7,000 positions is a substantial undertaking, comparable in scale to major corporate transformations seen in other large consumer goods companies aiming to streamline operations and improve profitability in challenging environments.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Organizational RestructuringReorganization of geographic regions to enhance accountability and streamline operations, aligning with recent leadership changes. New regions are The Americas, EUKEM, Asia/Pacific, and Mainland China (as a separate region).Fiscal 2026 first quarterExpected to streamline operations, enhance accountability, and better align with strategic priorities, potentially improving regional performance and resource allocation.

Legal Proceedings

  • The company reached agreements for talcum litigation settlement, recording a charge of $159 million in fiscal 2025 first quarter for current claims and estimated future claims from January 1, 2025, through December 31, 2029, with annual capped amounts per participating law firm.

Stakeholder Impact

  • **Shareholders:** Experienced a significant diluted net loss per common share of $(3.15) in fiscal 2025 and a reduction in the quarterly dividend to $.35 per share. However, the company forecasts a return to organic sales growth and improved profitability in fiscal 2026, aiming to restore a solid double-digit adjusted operating margin over the next few years, which could benefit shareholders long-term.
  • **Employees:** The Profit Recovery and Growth Plan (PRGP) includes an estimated net reduction in positions of 5,800 to 7,000, which will negatively impact affected employees. The plan also involves retraining and redeployment in select areas.
  • **Customers:** Increased consumer-facing investments and strategic pricing actions are aimed at fueling growth and new consumer acquisition. Expanded online distribution and product innovations are intended to enhance customer reach and experience.
  • **Suppliers:** The PRGP includes initiatives to optimize vendor management and reduce third-party labor-related costs, which could impact certain suppliers. The company is also mindful of the potential impact of PRGP changes on suppliers.
  • **Creditors:** Net cash flows provided by operating activities decreased, and higher restructuring payments are expected to peak in fiscal 2026, which could affect short-term liquidity, though the company continues to focus on managing working capital.

Next Steps

  • Continue to execute the strategic vision of 'Beauty Reimagined' with excellence.
  • Substantially complete actions under the Profit Recovery and Growth Plan (PRGP) by fiscal 2027, with a majority of full run-rate benefits expected in fiscal 2027.
  • Complete approvals for specific initiatives under the restructuring program by the end of fiscal 2026.
  • Reorganize geographic regions for reporting purposes, effective fiscal 2026 first quarter.
  • Continue to closely monitor evolving trade policies and enacted tariffs, and evaluate additional mitigation strategies including further PRGP initiatives and potential pricing actions.
  • Host a conference call on August 20, 2025, to discuss fiscal 2025 results.
  • Pay quarterly dividend of $.35 per share on September 16, 2025.

Key Dates

DateDescription
2024-08-01Annual goodwill and other indefinite-lived intangible asset impairment testing as of April 1, 2024, determined carrying value of Dr.Jart+ reporting unit and trademark exceeded estimated fair values.
2024-08-31Through August 2024, the company reached agreements for talcum litigation settlement.
2024-10-31Through October 2024, the company reached agreements for talcum litigation settlement.
2024-11-01Profit Recovery and Growth Plan (PRGP) communicated.
2024-12-01New BioTech Hub opened in Belgium.
2025-01-01Process for resolving potential future cosmetic talcum powder claims expected to be brought on behalf of plaintiffs by participating law firms begins.
2025-01-01Collaboration with the Massachusetts Institute of Technology established.
2025-02-03Company committed to the expansion of the PRGP, including an expansion of the restructuring program.
2025-02-05Company announced a two-year restructuring program as part of the PRGP.
2025-05-01KILIAN PARIS hosted an event during the Cannes Film Festival.
2025-06-30Fiscal year ended June 30, 2025.
2025-08-13As of this date, the company has approved initiatives totaling cumulative charges of $747 million and a net reduction of over 3,200 positions under the PRGP.
2025-08-20Financial results for fiscal year ended June 30, 2025, reported.
2025-08-20Conference call to discuss fiscal 2025 results.
2025-09-02Record date for quarterly dividend of $.35 per share.
2025-09-03Webcast replay of conference call available until this date.
2025-09-16Quarterly dividend of $.35 per share payable.
2026-06-30Expected completion of approvals for specific initiatives under the restructuring program.
2026-07-01The Ordinary's first launch in Amazon's U.K. Premium Beauty store and launch on Tmall.
2026-08-01Clinique's launch in Amazon.com.mx (Mexico) Premium Beauty store.
2026-12-31Process for resolving potential future cosmetic talcum powder claims expected to end.
2027-06-30Expected substantial completion of actions under the Profit Recovery and Growth Plan (PRGP).

Recommendation

hold

The company reported a very challenging fiscal 2025 with significant losses, sales declines, and substantial impairment charges, indicating past strategic missteps or overvaluations. This warrants caution. However, the outlined Profit Recovery and Growth Plan (PRGP) is a comprehensive restructuring effort designed to restore sales growth and improve profitability, with a clear forecast for a return to positive organic sales growth and improved adjusted operating margins in fiscal 2026. The company's strong brand portfolio and market share gains in key regions suggest underlying strength. Given the current poor performance but a credible path to recovery, a 'hold' recommendation is appropriate. Investors should monitor the execution of the PRGP and the realization of forecasted improvements before considering a 'buy' or 'sell' position.

Keywords

Prestige Beauty, Cosmetics, Skin Care, Makeup, Fragrance, Hair Care, SEC Filing, Financial Results, Earnings Report, Restructuring, Profit Recovery and Growth Plan, Global Travel Retail, China Market, Impairment Charges, Dividend, Consumer Goods, Luxury Brands, Estée Lauder, La Mer, MAC, Clinique, The Ordinary, Le Labo, Jo Malone London, TOM FORD

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.